PT - JOURNAL ARTICLE AU - Loupa, Glykeria AU - Karali, Dimitra AU - Rapsomanikis, Spyridon TI - Aerosol filtering efficiency of respiratory face masks used during the COVID-19 pandemic AID - 10.1101/2020.07.16.20155119 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.16.20155119 4099 - http://medrxiv.org/content/early/2020/07/21/2020.07.16.20155119.short 4100 - http://medrxiv.org/content/early/2020/07/21/2020.07.16.20155119.full AB - The spread of the COVID-19 pandemic, effected the imposition of personal protection measures in a large number of countries. The use of commercially available personal face masks was widely accepted as such a protective measure. Since the quality of the face masks scanned the spectrum from surgical to the home made fabric ones, it was considered appropriate to experimentally establish their effectiveness for stopping aerosol in entering the respiratory system of the bearer. Presently, only eight masks were tested with polydisperse indoor air. Their effectiveness was examined for aerosol of aerodynamic diameters of 0.006 μm to 10 μm. Of these masks, only two were effective for the whole range of aerosol. Cloth masks were found to be ineffective for the assigned task.Competing Interest StatementThe authors have declared no competing interest.Funding StatementInternal university fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NO PATIENTS involvedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesno available data